Gilead is obtaining closer to a bargain to acquire Immunomedics for greater than $20 billion

Gilead Sciences Inc is nearing a bargain to acquire biopharmaceutical firm Immunomedics Inc for greater than $20 billion in a bargain that would certainly better broaden Gilead’s profile of cancer cells therapies, the Wall surface …
Read More